{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:18:37Z","timestamp":1778876317468,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-0899-4","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T02:41:28Z","timestamp":1463452888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB"],"prefix":"10.1186","volume":"14","author":[{"given":"Vivek","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sao","family":"Puth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Oh","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shee Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Haeng","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"899_CR1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMsa1206589","volume":"368","author":"DC Payne","year":"2013","unstructured":"Payne DC, Vinje J, Szilagyi PG, Edwards KM, Staat MA, Weinberg GA, Hall CB, Chappell J, Bernstein DI, Curns AT, et al. Norovirus and medically attended gastroenteritis in US children. N Engl J Med. 2013;368:1121\u201330.","journal-title":"N Engl J Med"},{"key":"899_CR2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00284649","volume":"12","author":"M Hardy","year":"1996","unstructured":"Hardy M, Estes M. Completion of the norwalk virus genome sequence. Virus Genes. 1996;12:287\u201390.","journal-title":"Virus Genes"},{"key":"899_CR3","doi-asserted-by":"crossref","first-page":"e1002413","DOI":"10.1371\/journal.ppat.1002413","volume":"7","author":"N McFadden","year":"2011","unstructured":"McFadden N, Bailey D, Carrara G, Benson A, Chaudhry Y, Shortland A, Heeney J, Yarovinsky F, Simmonds P, Macdonald A, Goodfellow I. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog. 2011;7:e1002413.","journal-title":"PLoS Pathog"},{"key":"899_CR4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1099\/vir.0.059634-0","volume":"95","author":"LG Thorne","year":"2014","unstructured":"Thorne LG, Goodfellow IG. Norovirus gene expression and replication. J Gen Virol. 2014;95:278\u201391.","journal-title":"J Gen Virol"},{"key":"899_CR5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.chom.2014.05.015","volume":"15","author":"SM Karst","year":"2014","unstructured":"Karst SM, Wobus CE, Goodfellow IG, Green KY, Virgin HW. Advances in norovirus biology. Cell Host Microbe. 2014;15:668\u201380.","journal-title":"Cell Host Microbe"},{"key":"899_CR6","first-page":"4","volume-title":"Akkina R","author":"S Taube","year":"2013","unstructured":"Taube S, Kolawole AO, Hohne M, Wilkinson JE, Handley SA, Perry JW, Thackray LB. Akkina R. Wobus CE: A mouse model for human norovirus. MBio; 2013. p. 4."},{"key":"899_CR7","doi-asserted-by":"crossref","first-page":"e33235","DOI":"10.1371\/journal.pone.0033235","volume":"7","author":"AM Mulder","year":"2012","unstructured":"Mulder AM, Carragher B, Towne V, Meng Y, Wang Y, Dieter L, Potter CS, Washabaugh MW, Sitrin RD, Zhao Q. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine. PLoS One. 2012;7:e33235.","journal-title":"PLoS One"},{"key":"899_CR8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbrc.2011.04.048","volume":"408","author":"Q Zhao","year":"2011","unstructured":"Zhao Q, Wang Y, Abraham D, Towne V, Kennedy R, Sitrin RD. Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment. Biochem Biophys Res Commun. 2011;408:447\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"899_CR9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4161\/hv.6.5.11023","volume":"6","author":"M Deschuyteneer","year":"2014","unstructured":"Deschuyteneer M, Elouahabi A, Plainchamp D, Plisnier M, Soete D, Corazza Y, Lockman L, Giannini S, Deschamps M. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix\u2122, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine. Human Vaccines. 2014;6:407\u201319.","journal-title":"Human Vaccines"},{"key":"899_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4161\/hv.1.5.2126","volume":"1","author":"M Shank-Retzlaff","year":"2014","unstructured":"Shank-Retzlaff M, Wang F, Morley T, Anderson C, Hamm M, Brown M, Rowland K, Pancari G, Zorman J, Lowe R, et al. Correlation between mouse potency and in vitro relative potency for human papillomavirus type 16 virus-like particles and gardasil\u00ae vaccine samples. Human Vaccines. 2014;1:191\u20137.","journal-title":"Human Vaccines"},{"key":"899_CR11","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","volume":"8","author":"H Fang","year":"2013","unstructured":"Fang H, Tan M, Xia M, Wang L, Jiang X. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One. 2013;8:e63269.","journal-title":"PLoS One"},{"key":"899_CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2567.2011.03516.x","volume":"135","author":"K Tamminen","year":"2012","unstructured":"Tamminen K, Huhti L, Koho T, Lappalainen S, Hytonen VP, Vesikari T, Blazevic V. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology. 2012;135:89\u201399.","journal-title":"Immunology"},{"key":"899_CR13","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/JVI.78.12.6469-6479.2004","volume":"78","author":"R Chen","year":"2004","unstructured":"Chen R, Neill JD, Noel JS, Hutson AM, Glass RI, Estes MK, Prasad BV. Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol. 2004;78:6469\u201379.","journal-title":"J Virol"},{"key":"899_CR14","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"J Holmgren","year":"2005","unstructured":"Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11:S45\u201353.","journal-title":"Nat Med"},{"key":"899_CR15","first-page":"778","volume":"10","author":"Azmi F, Ahmad Fuaad AAH, Skwarczynski M, Toth I","year":"2013","unstructured":"Azmi F, Ahmad Fuaad AAH, Skwarczynski M, Toth I. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Hum Vaccin Immunother. 2013;10:778\u201396.","journal-title":"Hum Vaccin Immunother"},{"key":"899_CR16","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","volume":"19","author":"SG Reed","year":"2013","unstructured":"Reed SG, Orr MT, Fox CB. Key roles of adjuvants in modern vaccines. Nat Med. 2013;19:1597\u2013608.","journal-title":"Nat Med"},{"key":"899_CR17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"899_CR18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/IAI.74.1.694-702.2006","volume":"74","author":"SE Lee","year":"2006","unstructured":"Lee SE, Kim SY, Jeong BC, Kim YR, Bae SJ, Ahn OS, Lee JJ, Song HC, Kim JM, Choy HE, et al. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun. 2006;74:694\u2013702.","journal-title":"Infect Immun"},{"key":"899_CR19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0006-291X(89)80027-0","volume":"165","author":"N Ida","year":"1989","unstructured":"Ida N, Sakurai S, Hosaka T, Hosoi K, Kunitomo T, Shimazu T, Maruyama T, Matsuura Y, Kohase M. Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis. Biochem Biophys Res Commun. 1989;165:728\u201334.","journal-title":"Biochem Biophys Res Commun"},{"key":"899_CR20","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli L, Schwede T. Swiss-model: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42:W252\u20138.","journal-title":"Nucleic Acids Res"},{"key":"899_CR21","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","volume":"183","author":"IM Belyakov","year":"2009","unstructured":"Belyakov IM, Ahlers JD. What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? J Immunol. 2009;183:6883\u201392.","journal-title":"J Immunol"},{"key":"899_CR22","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.vaccine.2013.12.043","volume":"32","author":"S Gallorini","year":"2014","unstructured":"Gallorini S, Taccone M, Bonci A, Nardelli F, Casini D, Bonificio A, Kommareddy S, Bertholet S, O\u2019Hagan DT, Baudner BC. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses. Vaccine. 2014;32:2382\u20138.","journal-title":"Vaccine"},{"key":"899_CR23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/mi.2013.66","volume":"7","author":"L Maele Van","year":"2014","unstructured":"Van Maele L, Fougeron D, Janot L, Didierlaurent A, Cayet D, Tabareau J, Rumbo M, Corvo-Chamaillard S, Boulenouar S, Jeffs S, et al. Airway structural cells regulate TLR5-mediated mucosal adjuvant activity. Mucosal Immunol. 2014;7:489\u2013500.","journal-title":"Mucosal Immunol"},{"key":"899_CR24","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/j.vaccine.2015.05.022","volume":"33","author":"D Fougeron","year":"2015","unstructured":"Fougeron D, Van Maele L, Songhet P, Cayet D, Hot D, Van Rooijen N, Mollenkopf HJ, Hardt WD, Benecke AG, Sirard JC. Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract. Vaccine. 2015;33:3331\u201341.","journal-title":"Vaccine"},{"key":"899_CR25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature04267","volume":"438","author":"C Pasare","year":"2005","unstructured":"Pasare C, Medzhitov R. Control of B-cell responses by toll-like receptors. Nature. 2005;438:364\u20138.","journal-title":"Nature"},{"key":"899_CR26","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","volume":"185","author":"SB Mizel","year":"2010","unstructured":"Mizel SB, Bates JT. Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol. 2010;185:5677\u201382.","journal-title":"J Immunol"},{"key":"899_CR27","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1128\/IAI.73.10.6763-6770.2005","volume":"73","author":"O Pino","year":"2005","unstructured":"Pino O, Martin M, Michalek SM. Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses. Infect Immun. 2005;73:6763\u201370.","journal-title":"Infect Immun"},{"key":"899_CR28","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2011.10.058","volume":"30","author":"SH Hong","year":"2012","unstructured":"Hong SH, Byun YH, Nguyen CT, Kim SY, Seong BL, Park S, Woo GJ, Yoon Y, Koh JT, Fujihashi K, et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine. 2012;30:466\u201374.","journal-title":"Vaccine"},{"key":"899_CR29","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiu497","volume":"211","author":"DI Bernstein","year":"2015","unstructured":"Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinje J, Gregoricus N, Frenck RW Jr, Moe CL, et al. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. 2015;211:870\u20138.","journal-title":"J Infect Dis"},{"key":"899_CR30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.1014577107","volume":"108","author":"K Bok","year":"2011","unstructured":"Bok K, Parra GI, Mitra T, Abente E, Shaver CK, Boon D, Engle R, Yu C, Kapikian AZ, Sosnovtsev SV, et al. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci USA. 2011;108:325\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"899_CR31","doi-asserted-by":"crossref","first-page":"e1000236","DOI":"10.1371\/journal.ppat.1000236","volume":"4","author":"KA Chachu","year":"2008","unstructured":"Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog. 2008;4:e1000236.","journal-title":"PLoS Pathog"},{"key":"899_CR32","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1128\/JVI.00141-08","volume":"82","author":"KA Chachu","year":"2008","unstructured":"Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS. Virgin HWt: antibody is critical for the clearance of murine norovirus infection. J Virol. 2008;82:6610\u20137.","journal-title":"J Virol"},{"key":"899_CR33","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.4049\/jimmunol.175.3.1551","volume":"175","author":"G Caron","year":"2005","unstructured":"Caron G, Duluc D, Fremaux I, Jeannin P, David C, Gascan H, Delneste Y. Direct stimulation of human T cells via TLR5 and TLR7\/8: flagellin and R-848 up-regulate proliferation and IFN- production by memory CD4+ T cells. J Immunol. 2005;175:1551\u20137.","journal-title":"J Immunol"},{"key":"899_CR34","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.vaccine.2009.11.003","volume":"28","author":"CJ Braga","year":"2010","unstructured":"Braga CJ, Massis LM, Sbrogio-Almeida ME, Alencar BC, Bargieri DY, Boscardin SB, Rodrigues MM, Ferreira LC. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein. Vaccine. 2010;28:1373\u201382.","journal-title":"Vaccine"},{"key":"899_CR35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","volume":"25","author":"JW Huleatt","year":"2007","unstructured":"Huleatt JW, Jacobs AR, Tang J, Desai P, Kopp EB, Huang Y, Song L, Nakaar V, Powell TJ. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine. 2007;25:763\u201375.","journal-title":"Vaccine"},{"key":"899_CR36","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.4049\/jimmunol.172.11.6922","volume":"172","author":"A Didierlaurent","year":"2004","unstructured":"Didierlaurent A, Ferrero I, Otten LA, Dubois B, Reinhardt M, Carlsen H, Blomhoff R, Akira S, Kraehenbuhl JP, Sirard JC. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol. 2004;172:6922\u201330.","journal-title":"J Immunol"},{"key":"899_CR37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/bmj.2.3632.244","volume":"2","author":"AT Glenny","year":"1930","unstructured":"Glenny AT. Insoluble precipitates in diphtheria and tetanus immunization. Br Med J. 1930;2:244\u20135.","journal-title":"Br Med J"},{"key":"899_CR38","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.vaccine.2008.02.063","volume":"26","author":"L Bungener","year":"2008","unstructured":"Bungener L, Geeraedts F, Ter Veer W, Medema J, Wilschut J, Huckriede A. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. Vaccine. 2008;26:2350\u20139.","journal-title":"Vaccine"},{"key":"899_CR39","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","volume":"82","author":"N Petrovsky","year":"2004","unstructured":"Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol. 2004;82:488\u201396.","journal-title":"Immunol Cell Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-0899-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:46:07Z","timestamp":1498311967000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-016-0899-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-0899-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]},"article-number":"135"}}